Compare NRXS & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRXS | VATE |
|---|---|---|
| Founded | 2011 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Metal Fabrications |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.9M | 74.0M |
| IPO Year | 2023 | 1996 |
| Metric | NRXS | VATE |
|---|---|---|
| Price | $6.61 | $5.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $13.00 | N/A |
| AVG Volume (30 Days) | ★ 213.3K | 13.7K |
| Earning Date | 03-19-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.13 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $3,569,282.00 | ★ $1,246,000,000.00 |
| Revenue This Year | $142.91 | N/A |
| Revenue Next Year | $120.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 32.89 | 12.55 |
| 52 Week Low | $1.33 | $3.75 |
| 52 Week High | $7.97 | $8.28 |
| Indicator | NRXS | VATE |
|---|---|---|
| Relative Strength Index (RSI) | 51.68 | 64.68 |
| Support Level | $5.77 | $5.03 |
| Resistance Level | $7.97 | $5.52 |
| Average True Range (ATR) | 0.68 | 0.41 |
| MACD | -0.09 | 0.10 |
| Stochastic Oscillator | 25.91 | 91.53 |
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.